Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 1069-1074

  Ryder, Mabel ^a   Ghossein, Ronald A ^a   Ricarte Filho, Julio C M ^a   Knauf, Jeffrey A ^a   Fagin, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; THYROID CANCER; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SURVIVAL RATE; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 56649101166     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0036     Document Type: Article

References (20)

1. Andersen PE, Kinsella J, Loree TR, Shaba AR & Shah JP 1995 Differentiated carcinoma of the thyroid with extrathyroidal extension. American Journal of Surgery 170 467-470.
2. Bolat F 2006 Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. Journal of Experimental & Clinical Cancer Research 25 365-372.
3. Castellone MD, Guarino V, De F V, Carlomagno F, Basolo F, Faviana P, Kruhoffer M, Ormoft T, Russell JP, Rothstein JL et al. 2004 Functional expression of the CXCR4 chemokine receptor is induced by RET/ PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene 23 5958-5967.
4. Dhar DK, Kubota H, Kotoh T, Tabara H, Watanabe R, Tachibana M, Kohno H & Nagasue N 1998 Tumor vascularity predicts recurrence in differentiated thyroid carcinoma. American Journal of Surgery 176 442-447.
5. Fiumara A, Belfiore A, Russo G, Salomone E, Santonocito GM, Ippolito O, Vigneri R & Gangemi P 1997 In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 82 1615-1620.
6. Folkman J, Watson K, Ingber D & Hauahan D 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339 58-61.
7. Gray-Schopfer VC, Karasarides M, Hayward R & Marais R 2007 Tumor necrosis factor-α blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Research 67 122-129.
8. Herrmann G, Schumm-Graeger P-M, Muller C, Atai E, Wenzel B, Fabian T, Henning K, Usadel KH & Huber K 1994 T lymphocytes, CD68-positive cells and vascularization in thyroid carcinomas. Journal of Cancer Research and Clinical Oncology 120 651-656.
9. Hwang JH, Hwang JH, Chung HK, Kim DW, Hwang ES, Sub JM, Kim H, You KH, Kwon OY, Ro HK et al. 2003 CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. Journal of Clinical Endocrinology and Metabolism 88 408-416.
10. van Kempen LC & Coussens LM 2002 MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2 251-252.
11. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J & Harris AL 1996 Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Research 56 4625-4629.
12. Lewis CE & Pollard JW 2006 Distinct role of macrophages in different tumor microenvironments. Cancer Research 66 605-612.
13. Lewis CE, De Palma M & Naldini L 2007 Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Research 67 8429-8432.
14. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN & Pollard JW 2006 Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Research 66, 11238-11246.
15. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L & Bergh A 2000 Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. International Journal of Oncology 17 445-451.
16. Mantovani A 1994 Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Laboratory Investigation 71 5-16.
17. Mesa C Jr, Mirza M, Mitsutake N, Sartor M, Medvedovic M, Tomlinson C, Knauf JA, Weber GF & Fagin JA 2006 Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling. Cancer Research 66 6521-6529.
18. Schoppmann SF, Birner P, StockI J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K & Kerjaschki D 2002 Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. American Journal of Pathology 161 947-956.
19. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H & Era S 2005 Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncology Reports 14 425-431.
20. Yu JL 2003 Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Research 5 83-88.